Virginia Retirement Systems’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
ACG
EAM
JMFC
Virginia Retirement Systems's DNA Position: Q1 2026 in Review
Virginia Retirement Systems sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 13,200 shares — an estimated $110K sold.
Virginia Retirement Systems first reported a position in DNA in Q1 2025 and held it in 4 quarters. The position peaked at $192K in Q3 2025. 175 funds tracked by Wall St. Rank hold DNA as of Q1 2026.
- Virginia Retirement Systems reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
- Virginia Retirement Systems sold 13,200 Ginkgo Bioworks shares in Q1 2026, an estimated $110K.
- Virginia Retirement Systems first reported a position in Ginkgo Bioworks in Q1 2025 and held it in 4 quarters.
- Virginia Retirement Systems's Ginkgo Bioworks position peaked at $192K in Q3 2025.
- 175 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.
Based on Virginia Retirement Systems's 13F filing for Q1 2026, filed 25 Aug 2026.